Mike Hannay

Title: The Innovative Contributions of Mike Hannay

Introduction

Mike Hannay is a notable inventor based in Wachtberg-Villiprott, Germany. He has made significant contributions to the field of transdermal delivery systems, particularly in the administration of rotigotine. With a total of 3 patents to his name, Hannay's work has the potential to impact the medical industry positively.

Latest Patents

Hannay's latest patents include an improved transdermal delivery system (TDS) for the administration of rotigotine. The first patent describes a TDS that comprises a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine, and a protective foil or sheet to be removed prior to use. This system is characterized by a self-adhesive matrix made of a solid or semi-solid semi-permeable polymer. The second patent also focuses on an improved TDS, which features a self-adhesive matrix containing rotigotine in its free base form as a multitude of microreservoirs within the matrix. This matrix is designed to be highly permeable to the free base of rotigotine while remaining impermeable to its protonated form.

Career Highlights

Mike Hannay is currently employed at UCB Pharma GmbH, where he continues to innovate in the field of pharmaceutical delivery systems. His work has garnered attention for its potential to enhance the effectiveness of medication administration through transdermal methods.

Collaborations

Hannay collaborates with esteemed colleagues such as Dietrich Wilhelm Schacht and Hans-Michael Wolff. Their combined expertise contributes to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Mike Hannay's contributions to transdermal delivery systems exemplify the importance of innovation in medicine. His patents reflect a commitment to improving patient care through advanced technology.